Universal Oligonucleotide Primers for HIV-1 M and O Group Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current HIV-1 detection assays struggle to accurately measure the full range of HIV-1 subtypes due to genetic diversity, particularly in regions where subtypes other than Glade B predominate, necessitating the development of ultrasensitive assays capable of detecting HIV-1 M, O, and N groups with high specificity and sensitivity.
Innovation Solution
A reaction mixture and method utilizing specific amplification primers and hybridization probes that can hybridize to both HIV-1 M and O group nucleic acids, allowing for simultaneous amplification and detection with equal efficiency, using isothermal transcription-associated amplification reactions like TMA or NASBA, and employing molecular beacons or torches for signal monitoring.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional HIV-1 detection assays are used, then detection of Glade B subtype is adequate, but detection accuracy deteriorates for diverse HIV-1 subtypes (M, O, N groups)
Solution Approach 1:
The patent designs primers and probes with universal binding characteristics that can recognize and bind to multiple HIV-1 subtypes (M, O, and N groups) simultaneously. The primer sequences are selected from conserved regions of the HIV-1 genome that exhibit high sequence similarity across different subtypes, enabling a single assay to detect diverse viral variants with comparable accuracy to subtype-specific assays.
2Reliability
If highly active anti-retroviral drug therapy (HAART) is applied, then viral load is reduced below early detection limits, but measurement sensitivity requirements increase
Solution Approach 1:
The patent employs a two-stage amplification process where target nucleic acids are first amplified using subtype-universal primers to generate sufficient copy numbers, then detected using highly specific probes. This preliminary amplification step concentrates low-abundance viral targets, enabling detection of viral loads below 50 copies/mL while maintaining subtype discrimination capability.
Solution Approach 2:
The patent introduces hybridization probes as intermediary detection elements that bridge the amplified target sequences and detection systems. These probes provide high-specificity recognition of HIV-1 sequences regardless of subtype variations, enabling sensitive detection of ultra-low viral loads while maintaining reliability in distinguishing HIV-1 from other viruses or background nucleic acids.
3Adaptability or versatility
If multiple subtype-specific assays are used to cover all HIV-1 variants, then detection coverage improves, but assay complexity increases
Solution Approach 1:
The patent merges multiple subtype-specific detection capabilities into a single unified assay system. By selecting primer binding sites from highly conserved regions of the HIV-1 genome and using probes that recognize common subtype features, the assay simultaneously detects M, O, and N group viruses in one reaction mixture, eliminating the need for separate subtype-specific assays while maintaining comprehensive coverage.
4Productivity
If conventional PCR-based amplification is used, then amplification efficiency is adequate for high viral loads, but sensitivity deteriorates for low viral loads below detection thresholds
Solution Approach 1:
The patent employs isothermal amplification methods that continuously amplify target nucleic acids without thermal cycling, maintaining constant optimal conditions for enzyme activity throughout the reaction. This continuous amplification process efficiently generates detectable signal levels from ultra-low starting template concentrations (below 50 copies/mL) while preserving the high productivity of conventional PCR for higher viral loads.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate and sensitive quantification of combined HIV-1 M and O group nucleic acids in a single reaction, improving detection capabilities across diverse HIV-1 subtypes, including those present in low concentrations, and allows for the use of a single standard curve for quantification.
Implementation Method 1
The first amplification primer includes a first primer target-hybridizing sequence that can independently hybridize to a first strand of HIV-1 M group nucleic acids, and to a first strand of HIV-1 O group nucleic acids
Implementation Method 2
The second amplification primer includes a second primer target-hybridizing sequence that hybridizes to an enzymatic extension product of the first amplification primer using as a template either the first strand of HIV-1 M group nucleic acids or the first strand of HIV-1 O group nucleic acids
Implementation Method 3
using isothermal transcription-associated amplification reactions like TMA or NASBA
Implementation Method 4
employing molecular beacons or torches for signal monitoring
Data Source
AI summary
Oligonucleotide primer useful for synthesizing a cDNA copy of HIV-1 nucleic acids from a broad range of HIV-1 subtypes, including M group and O group variants.